Type / Class
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Shares outstanding
264M
Number of holders
29
Total 13F shares, excl. options
8.99M
Shares change
-2.71M
Total reported value, excl. options
$7.41M
Value change
-$2.24M
Put/Call ratio
0.67
Number of buys
9
Number of sells
-8
Price
$0.82

Significant Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q1 2025

34 filings reported holding NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) as of Q1 2025.
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 8.99M shares of 264M outstanding shares and own 3.4% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (5.98M shares), SG Americas Securities, LLC (822K shares), Stonepine Capital Management, LLC (484K shares), TWO SIGMA ADVISERS, LP (363K shares), UBS Group AG (319K shares), TWO SIGMA INVESTMENTS, LP (210K shares), Aberdeen Group plc (163K shares), BNP PARIBAS FINANCIAL MARKETS (121K shares), Alberta Investment Management Corp (74.7K shares), and RENAISSANCE TECHNOLOGIES LLC (63.8K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.